Evidence map›Paper›PMID 32860125›Full record

ArticleEuropean journal of nutrition2021

Sucralose can improve glucose tolerance and upregulate expression of sweet taste receptors and glucose transporters in an obese rat model.

Cheng Qian, Yicheng Qi, Rilu Feng, Mei Yang, Minchun Zhang, Wei Liu, Christopher K Rayner, Jing Ma

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cheng Qian *Department of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Yicheng Qi *Department of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Rilu FengDepartment of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Mei YangDepartment of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Minchun ZhangDepartment of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Wei LiuDepartment of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China.
Christopher K RaynerCentre of Research Excellence in Translating Nutritional Science To Good Health, University of Adelaide, Adelaide, SA, 5000, Australia.
Jing MaDepartment of Endocrinology and Metabolism, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160# Pujian Road, Pudong, Shanghai, 200127, China. majing3436@163.com.

Funding

National Natural Science Foundation of China 81670728National Natural Science Foundation of China 81800693Shanghai Pujiang Program 2019PJD027
6 · The paper itself

Abstract

objectivesNon-nutritive sweeteners (NNS) are widely used as replacements for table sugar in beverages and dessert. However, the metabolic effects of NNS remain controversial. This study aimed to investigate the effects of various sucralose loads on glucose metabolism and expression of sweet taste receptors (STR) and glucose transporters in a high-fat diet (HFD) rats.

methodsFour-week-old male Sprague Dawley rats were fed a HFD for 8 weeks, then randomly divided into eight groups (6 in each group). All were gavaged with either saline, sucralose (0.54 mM or 0.78 mM), or sucrose (324 mM) with/without gurmarin, a sweet taste inhibitor, for 4 weeks, followed by an intragastric glucose tolerance test (IGGTT) with blood glucose, and plasma insulin, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) measurements. In the following week, the rats were sacrificed and the small intestine was removed for measurement of sweet taste receptor and glucose transporter expression by quantitative Reverse Transcription-Polymerase Chain Reaction.

resultsIn HFD rats, blood glucose levels were decreased at 30, 60, and 120 min during the IGGTT after 4 weeks supplementation with 0.78 mM sucralose. TIR3 expression was increased in the duodenum and TIR2 was increased in the ileum after 324 mM sucrose supplementation. T1R3 expression was increased after 0.54 mM and 0.78 mM sucralose in the ileum, but there was no change in the expression of TIRs in the duodenum after sucralose treatments. SGLT-1 expression was increased after both 0.78 mM sucralose and 324 mM sucrose in the ileum, and only increased in the duodenum after 324 mM sucrose supplementation.

conclusionsThe effects of sucralose on glucose metabolism in HFD rats are dose-dependent and related to enhanced expression of sweet taste receptors and glucose transporters. Further studies are needed to clarify the molecular mechanisms involved.

Indexed as

Glucose Transport Proteins, FacilitativeTasteAnimalsBlood GlucoseMaleObesityRatsRats, Sprague-DawleySucroseSweetening AgentsBlood GlucoseGlucose Transport Proteins, FacilitativeSucroseSweetening AgentstrichlorosucroseGLP-1Intragastric glucose tolerance testNon-nutritive sweetenersSGLT-1Sweet taste receptors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.